دورية أكاديمية
أعرض في EDS

Peritoneal cell-free DNA as a sensitive biomarker for detection of peritoneal metastasis in colorectal cancer: a prospective diagnostic study

التفاصيل البيبلوغرافية
العنوان: Peritoneal cell-free DNA as a sensitive biomarker for detection of peritoneal metastasis in colorectal cancer: a prospective diagnostic study
المؤلفون: Zixu Yuan, Wenle Chen, Duo Liu, Qiyuan Qin, William M. Grady, Alessandro Fichera, Huaiming Wang, Ting Hou, Xinze Lv, Chanhe Li, Hui Wang, Jian Cai
المصدر: Clinical Epigenetics, Vol 15, Iss 1, Pp 1-14 (2023)
بيانات النشر: BMC, 2023.
سنة النشر: 2023
المجموعة: LCC:Medicine
LCC:Genetics
مصطلحات موضوعية: Peritoneal metastasis, Colorectal cancer, Cell-free DNA, NGS, Driver mutations, Medicine, Genetics, QH426-470
الوصف: Abstract Background The detection of peritoneal metastasis (PM) is limited by current imaging tools. In this prospective study, we aimed to evaluate the sensitivity and specificity of peritoneal cell-free DNA (cfDNA) for diagnosis of PM. Methods Colorectal cancer (CRC) patients with/without PM were enrolled. The cfDNA experimental personnel and statists were blinded to the diagnosis of PM. Ultradeep sequencing covering large genomic regions (35000X, Next-generation sequencing) of cfDNA in peritoneal lavage fluid (FLD) and matched tumor tissues was performed. Results A total of 64 cases were recruited prospectively and 51 were enrolled into final analysis. In training cohort, 100% (17/17) PM patients obtained positive FLD cfDNA, comparing to 5/23 (21.7%) in patients without PM. Peritoneal cfDNA had a high sensitivity of 100% and specificity of 77.3% for diagnosis of PM (AUC: 0.95). In validation group of 11, 5/6 (83%) patients with PM obtained positive FLD cfDNA, comparing to 0/5 in non-PM (P = 0.031) with a sensitivity of 83.3% and specificity of 100%. Positive FLD cfDNA was associated with poor recurrence-free survival (P = 0.013) and was preceding radiographic evidence of recurrence. Conclusions Peritoneal cfDNA is a promising sensitive biomarker for earlier detection of PM in CRC than current radiological tools. It can potentially guide selection for targeted therapies and serve as a surrogate instead of laparoscopic explore in the future. Trial Registration Chinese Clinical Trial Registry at chictr.org.cn (ChiCTR2000035400). URL: http://www.chictr.org.cn/showproj.aspx?proj=57626
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 1868-7083
Relation: https://doaj.org/toc/1868-7083
DOI: 10.1186/s13148-023-01479-9
URL الوصول: https://doaj.org/article/804e5061764f467a96751f023173b084
رقم الأكسشن: edsdoj.804e5061764f467a96751f023173b084
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:18687083
DOI:10.1186/s13148-023-01479-9